Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic HR+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor–Positive Breast Cancer
Breast Cancer (Auckl) 2020 Feb 01;14(xx)1178223420976387, M Sarma, Y Abdou, A Dhakal, S GandhiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.